---
$id: https://graph.org.ai/products/commodity/51181603
$type: Product
source: UNSPSC
code: "51181603"
title: "Liotrix"
class: "51181600"
classTitle: "Thyroid and antithyroid drugs"
family: "51180000"
familyTitle: "Hormones and hormone antagonists"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Liotrix

**UNSPSC Code**: 51181603
**Class**: [Thyroid and antithyroid drugs](Thyroid and antithyroid drugs.mdx)
**Family**: [Hormones and hormone antagonists](../Hormones and hormone antagonists.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thyroid hormone and thyroxine-triiodothyronine drug combination with the molecular formula C30H23I7N2O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YW8HJ0N26X, more generally known as liotrix, chemically known as (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid;(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3, 5-diiodophenyl]propanoic acid, but generally known as liotrix. As of Q4 2014, LIOTRIX remains the US FDA Preferred Term for this commodity. Liotrix bears US NLM identifiers UMLS ID C0936106 and NCI Concept Code C87251. SMILES: C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O.C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N.

